Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous SystemBusiness Wire • 04/01/21
Biocept, Inc. (BIOC) CEO Michael Nall on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/30/21
Biocept posts first-ever quarterly profit and balloons 4Q revenue to $18.5M on strength of coronavirus testingProactive Investors • 03/29/21
Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021Business Wire • 03/22/21
Biocept changing the way physicians examine blood work for their cancer patients and doing coronavirus testingProactive Investors • 03/18/21
Biocept strikes supply agreement with Aegea Biotechnologies for co-developed ultra-sensitive coronavirus detection testProactive Investors • 03/02/21
Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral LoadBusiness Wire • 03/02/21
Biocept Inks Research Pact With Protean BioDiagnostics For Target Selector Kit Advantages In Lung CancerBenzinga • 02/23/21
Biocept teams up with Protean BioDiagnostics to study Target Selector in determining EGFR mutations in tumor samplesProactive Investors • 02/23/21
Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept's Target Selector™ Assay Kit for Non-Small Cell Lung Cancer PatientsBusiness Wire • 02/23/21
Biocept to present study showcasing its ultra-sensative Target Selector biopsy assay kits at a virtual medical conference this weekProactive Investors • 02/16/21
Study Shows Biocept's Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer PatientsBusiness Wire • 02/16/21
Biocept Provides Update on COVID-19 Testing with More than 250,000 Samples ReceivedBusiness Wire • 02/03/21
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician AssociationsPRNewsWire • 12/30/20
Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central Nervous SystemPRNewsWire • 11/20/20
Biocept, Inc. (BIOC) CEO Michael Nall on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/20
Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples ReceivedPRNewsWire • 11/12/20
